BrainsWay Ltd. BWAY
Set alert
At close
Pre-market · Nov 2, 4:02 AM ET
- YTD
- +19.45%
- 1 year
- +33.80%
- Open
- 11.58
- Prev close
- 11.93
- Mkt cap
- 457.27M
- Vol
- 123.87K
- Avg vol
- 107.05K
- EPS
- 0.23
- P/E
- 49.39
- Div yield
- 0.00%
More statistics
- Low
- 11.16
- High
- 11.58
- Forward P/E
- 91.50
- Beta
- 0.37
- Short ratio
- 0.33
- Inst. own
- 19.22%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 9.84
- 200-d avg
- 7.41
- 1y target
- 13.73
5D chart
Signals (130)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:35 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:25 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 3:05 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:55 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:50 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:45 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:40 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:35 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:35 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:05 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:40 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:30 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:55 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:40 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:30 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:25 AM | 2 days ago |
| RSI: Oversold | Oct 30, 10:05 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:45 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:35 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:15 PM | 3 days ago |
| RSI: Overbought | Oct 29, 11:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:25 AM | 3 days ago |
| RSI: Overbought | Oct 29, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:15 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:40 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:20 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:15 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:55 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:10 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:10 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:55 AM | 4 days ago |
| RSI: Oversold | Oct 28, 11:55 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:50 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:15 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:10 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:10 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:30 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:05 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:40 PM | 5 days ago |
| RSI: Overbought | Oct 27, 11:55 AM | 5 days ago |
| RSI: Overbought | Oct 27, 11:15 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:10 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:10 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:05 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 5 days ago |
| RSI: Overbought | Oct 27, 10:25 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 6 days ago |
| MACD: Buy Signal | Oct 27, 9:35 AM | 6 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 6 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:50 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:45 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:45 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:30 PM | 6 days ago |
| RSI: Oversold | Oct 26, 1:30 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:00 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:55 PM | 6 days ago |
| RSI: Overbought | Oct 26, 12:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:15 AM | 6 days ago |
News
-
1 hour ago benzinga.com
BrainsWay Partners With Mindful Health Solutions To Pursue Strategic Initiatives To Expand Patient Access To Health Treatments
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced a strategic
5 days ago globenewswire.com
BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026
BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced non-invasive neurostimulation…
1 week ago globenewswire.com
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
BURLINGTON, Mass. and JERUSALEM, Oct. 26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation…
-
1 week ago benzinga.com
HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $19 price target.
-
2 weeks ago benzinga.com
BrainsWay, Inland Psychiatric Collaborate On Multi-System Deep TMS Deployment And Mental Health Research Initiatives
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced non-invasive neurostimulation treatments for mental health disorders, today announced a strategic
2 weeks ago globenewswire.com
BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group
Partnership with Established Southern California Behavioral Health Provider Aims to Accelerate Innovative Application of Interventional Psychiatry Treatments Partnership with Established Southern…
2 weeks ago benzinga.com
Bumble, Fermi, Xtend AI Robotics And Other Big Stocks Moving Higher On Tuesday
U.S. stocks mostly fell; Bumble surged 56.7% on Ithaca’s $6.05 buyout offer, while Fermi, Enerflex, BigBear.ai and others gained.
2 weeks ago globenewswire.com
BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
BURLINGTON, Mass. and JERUSALEM, Oct. 13, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation…
3 weeks ago defenseworld.net
HWG Holdings LP Buys New Stake in Brainsway Ltd. Sponsored ADR $BWAY
HWG Holdings LP purchased a new stake in Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange…
3 weeks ago defenseworld.net
Head to Head Survey: CapsoVision (NASDAQ:CV) vs. Brainsway (NASDAQ:BWAY)
CapsoVision (NASDAQ: CV - Get Free Report) and Brainsway (NASDAQ: BWAY - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two…
1 month ago defenseworld.net
Brainsway (NASDAQ:BWAY) Shares Gap Down – What’s Next?
Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY - Get Free Report)'s share price gapped down prior to trading on Tuesday. The stock had previously closed at $13.57, but opened at $13.14. Brainsway shares…
-
1 month ago benzinga.com
HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $19 price target.
1 month ago globenewswire.com
BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer's Disease Treated with Deep TMS™
Peer-reviewed pilot study shows 83.3% response rate and 50% remission rate in depressive symptoms, alongside measurable neurophysiological changes in brain activity and connectivity
2 months ago benzinga.com
Snowflake To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BMO…
-
2 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $19
HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $17 to $19.
2 months ago defenseworld.net
Analyzing Brainsway (NASDAQ:BWAY) and Green Thumb Industries (OTCMKTS:GTBIF)
Brainsway (NASDAQ: BWAY - Get Free Report) and Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast…
2 months ago zacks.com
Wall Street Analysts See a 30.07% Upside in Brainsway (BWAY): Can the Stock Really Move This High?
The mean of analysts' price targets for Brainsway (BWAY) points to a 30.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among…
2 months ago zacks.com
Brainsway (BWAY) Upgraded to Buy: Here's Why
Brainsway (BWAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2 months ago defenseworld.net
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Receives $16.95 Average Target Price from Brokerages
Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the company, Marketbeat Ratings…
-
2 months ago benzinga.com
Ladenburg Thalmann Maintains Buy on BrainsWay, Raises Price Target to $18.8
Ladenburg Thalmann analyst Jeffrey Cohen maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $18 to $18.8.
2 months ago marketbeat.com
Brainsway Q2 Earnings Call Highlights
Brainsway NASDAQ: BWAY reported second-quarter revenue growth of 35% and raised its full-year 2026 revenue outlook, citing continued demand for its Deep TMS systems, expanding reimbursement for its…
2 months ago seekingalpha.com
BrainsWay Ltd. (BWAY) Q2 2026 Earnings Call Transcript
BrainsWay Ltd. (BWAY) Q2 2026 Earnings Call Transcript
-
2 months ago benzinga.com
BrainsWay Raises FY2026 Sales Guidance from $66.000M-$68.000M to $68.000M-$70.000M vs $67.819M Est
BrainsWay (NASDAQ:BWAY) raises FY2026 sales outlook from $66.000 million-$68.000 million to $68.000 million-$70.000 million vs $67.819 million estimate.
-
2 months ago benzinga.com
BrainsWay Q2 EPS $0.07 Misses $0.08 Estimate, Sales $17.107M Beat $16.497M Estimate
BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12.5 percent. This is a 40 percent increase over earnings of $0.05 per…
2 months ago globenewswire.com
BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
Record s econd q uarter 2026 r evenue increased 35% t o $17. 1 m illion, compared with Q2 2025
2 months ago seekingalpha.com
BrainsWay: Building A Capital-Light Interventional Psychiatry Ecosystem
BrainsWay is transitioning from a device manufacturer to a capital-light ecosystem provider for interventional psychiatry, leveraging recurring revenue and minority investments. BWAY reported Q1-2026…
3 months ago defenseworld.net
Brainsway (NASDAQ:BWAY) Sets New 52-Week High – Here’s What Happened
Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY - Get Free Report)'s share price hit a new 52-week high during trading on Friday. The company traded as high as $17.50 and last traded at $17.50, with a…
3 months ago zacks.com
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through…
3 months ago zacks.com
4 Medical Products Stocks Poised to Win Despite Industry Headwinds
Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation, pricing and execution as healthcare demand stays resilient.
3 months ago globenewswire.com
BrainsWay Announces Strategic Investment in Radial Health, Inc.
BrainsWay continues to actively evaluate similar investments in leading North American mental health providers to raise awareness and expand access to transformative care BrainsWay continues to…
-
3 months ago benzinga.com
BTIG Initiates Coverage On BrainsWay with Buy Rating, Announces Price Target of $18
BTIG analyst Sam Eiber initiates coverage on BrainsWay (NASDAQ:BWAY) with a Buy rating and announces Price Target of $18.
-
3 months ago benzinga.com
BrainsWay To Invest $500,000 For Minority Position In Sound Minds In The Form Of Preferred, Annually Compounding Security
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its participation
-
4 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $17 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $17 price target.
-
4 months ago benzinga.com
BrainsWay Presents New Data On Enhancements In Participants With Comorbid Post-Traumatic Stress Disorder, Major Depressive Disorder With Deep Transcranial Magnetic Stimulation
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies, today announced the presentation of positive new
-
4 months ago benzinga.com
BrainsWay Expands Insurance Coverage for Faster Depression Treatment
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical
-
4 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $17 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $17 price target.
-
4 months ago benzinga.com
BrainsWay Presents New Prospective 12-Month Durability Data Demonstrating Sustained Clinical Benefits Following Accelerated Deep Transcranial Magnetic Stimulation For Major Depressive Disorder
BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data…
-
5 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $17
HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $15 to $17.
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
7 months ago benzinga.com
Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Dow futures down 0.2%. Hesai Group -ADR shares drop 6.6% after reporting lower quarterly earnings and sales. Other stocks also down in pre-market.
7 months ago benzinga.com
Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Dow futures down 0.2%. Hesai Group -ADR shares drop 6.6% after reporting lower quarterly earnings and sales. Other stocks also down in pre-market.
7 months ago benzinga.com
Micron To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday
Top analysts change outlook on top names. HC Wainwright cut BWAY price target, Mizuho raised PENN target, Telsey slashed SFIX target, BTIG cut AVAV target, Barrington cut CURI target, Morgan Stanley…
-
7 months ago benzinga.com
Earnings Scheduled For March 11, 2026
Earnings Scheduled For March 11, 2026
8 months ago benzinga.com
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1
Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term performance. Latest list of oversold players with RSI below 30: GOSS (26.3), BWAY (19.1), DH (20.2).
8 months ago benzinga.com
Molson Coors Beverage, Carvana, Avis Budget And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Molson Coors Beverage, Carvana, Avis Budget And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
9 months ago benzinga.com
Meta To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday
Meta To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday
11 months ago benzinga.com
Earnings Scheduled For November 11, 2025
Earnings Scheduled For November 11, 2025
-
1 year ago benzinga.com
Earnings Scheduled For August 13, 2025
Earnings Scheduled For August 13, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session